These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8412185)

  • 1. DNA adducts in model systems and humans.
    Turteltaub KW; Frantz CE; Creek MR; Vogel JS; Shen N; Fultz E
    J Cell Biochem Suppl; 1993; 17F():138-48. PubMed ID: 8412185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the DNA adduction and pharmacokinetics of PhIP and MeIOx in rodents at doses approximating human exposure using the technique of accelerator mass spectrometry (AMS) and 32P-postlabeling.
    Turteltaub KW; Vogel JS; Frantz C; Felton JS; McManus M
    Princess Takamatsu Symp; 1995; 23():93-102. PubMed ID: 8844800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of DNA adduct studies in animal models for cancer molecular dosimetry and risk assessment.
    Beland FA; Poirier MC
    Environ Health Perspect; 1993 Mar; 99():5-10. PubMed ID: 8319658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicological significance of DNA adducts: summary of discussions with an expert panel.
    Nestmann ER; Bryant DW; Carr CJ
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):9-18. PubMed ID: 8921541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-diet interactions in exposure to heterocyclic aromatic amines and bulky DNA adduct levels in blood leukocytes.
    Ho V; Peacock S; Massey TE; Godschalk RW; van Schooten FJ; Chen J; King WD
    Environ Mol Mutagen; 2015 Aug; 56(7):609-20. PubMed ID: 26010176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts.
    Levy GN; Weber WW
    Anal Biochem; 1988 Nov; 174(2):381-92. PubMed ID: 3239743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogen-DNA adducts in bladder biopsies and urothelial cells: a risk assessment exercise.
    Talaska G; Schamer M; Casetta G; Tizzani A; Vineis P
    Cancer Lett; 1994 Aug; 84(1):93-7. PubMed ID: 8076366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans.
    Talaska G; Roh JH; Getek T
    J Chromatogr; 1992 Sep; 580(1-2):293-323. PubMed ID: 1400827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: a new technique for tracing isotope-labelled DNA adduction.
    Turteltaub KW; Vogel JS; Frantz CE; Fultz E
    IARC Sci Publ; 1993; (124):293-301. PubMed ID: 8225498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
    Badawi AF; Stern SJ; Lang NP; Kadlubar FF
    Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment of DNA-reactive carcinogens in food.
    Jeffrey AM; Williams GM
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):628-35. PubMed ID: 15990138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
    Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
    Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma.
    Rojas M; Marie B; Vignaud JM; Martinet N; Siat J; Grosdidier G; Cascorbi I; Alexandrov K
    Cancer Lett; 2004 Apr; 207(2):157-63. PubMed ID: 15072824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adduction of the heterocyclic amine food mutagens IQ and PhIP to mitochondrial and nuclear DNA in the liver of Fischer-344 rats.
    Davis CD; Schut HA; Snyderwine EG
    Carcinogenesis; 1994 Apr; 15(4):641-5. PubMed ID: 8149474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue distribution of DNA adducts in rats treated by intramammillary injection with dibenzo[a,l]pyrene, 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene.
    Arif JM; Smith WA; Gupta RC
    Mutat Res; 1997 Aug; 378(1-2):31-9. PubMed ID: 9288883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
    Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC
    Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogen-DNA adducts as a biomarker for cancer risk.
    Rundle A
    Mutat Res; 2006 Aug; 600(1-2):23-36. PubMed ID: 16824556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogen-DNA adducts as tools in risk assessment.
    Airoldi L; Pastorelli R; Magagnotti C; Fanelli R
    Adv Exp Med Biol; 1999; 472():231-40. PubMed ID: 10736630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogen-DNA and carcinogen-protein adducts in molecular epidemiology.
    Wild CP; Pisani P
    IARC Sci Publ; 1997; (142):143-58. PubMed ID: 9354917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.